JP2006528147A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528147A5
JP2006528147A5 JP2006520762A JP2006520762A JP2006528147A5 JP 2006528147 A5 JP2006528147 A5 JP 2006528147A5 JP 2006520762 A JP2006520762 A JP 2006520762A JP 2006520762 A JP2006520762 A JP 2006520762A JP 2006528147 A5 JP2006528147 A5 JP 2006528147A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
group
compound
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006520762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528147A (ja
Filing date
Publication date
Priority claimed from GB0316893A external-priority patent/GB0316893D0/en
Priority claimed from GB0411167A external-priority patent/GB0411167D0/en
Application filed filed Critical
Priority claimed from PCT/EP2004/008061 external-priority patent/WO2005014571A1/en
Publication of JP2006528147A publication Critical patent/JP2006528147A/ja
Publication of JP2006528147A5 publication Critical patent/JP2006528147A5/ja
Pending legal-status Critical Current

Links

JP2006520762A 2003-07-18 2004-07-16 ヒスタミンh3受容体リガンドとしての置換ピペリジン Pending JP2006528147A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0316893A GB0316893D0 (en) 2003-07-18 2003-07-18 Novel compounds
GB0411167A GB0411167D0 (en) 2004-05-19 2004-05-19 Novel compounds
PCT/EP2004/008061 WO2005014571A1 (en) 2003-07-18 2004-07-16 Substituted piperidines as histamine h3 receptor ligands

Publications (2)

Publication Number Publication Date
JP2006528147A JP2006528147A (ja) 2006-12-14
JP2006528147A5 true JP2006528147A5 (https=) 2007-07-19

Family

ID=34137741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520762A Pending JP2006528147A (ja) 2003-07-18 2004-07-16 ヒスタミンh3受容体リガンドとしての置換ピペリジン

Country Status (9)

Country Link
US (1) US20060247227A1 (https=)
EP (1) EP1646620B1 (https=)
JP (1) JP2006528147A (https=)
AR (1) AR045999A1 (https=)
AT (1) ATE370135T1 (https=)
DE (1) DE602004008291T2 (https=)
ES (1) ES2291913T3 (https=)
TW (1) TW200514781A (https=)
WO (1) WO2005014571A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007010350A1 (en) * 2005-07-19 2007-01-25 Pfizer Products Inc. Synthesis of therapeutic diphenyl ethers
US7851474B2 (en) 2005-08-02 2010-12-14 Neurogen Corporation Dipiperazinyl ketones and related analogues
JP5603770B2 (ja) 2007-05-31 2014-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr2受容体拮抗薬およびその使用
CA2700963A1 (en) * 2007-09-28 2009-04-09 Schering Corporation Oxypiperidine derivatives and methods of use thereof
CN102256963B (zh) 2008-12-19 2014-06-11 贝林格尔.英格海姆国际有限公司 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
ES2674275T3 (es) 2009-12-17 2018-06-28 Centrexion Therapeutics Corporation Antagonistas del receptor CCR2 y usos de los mismos
JP5646736B2 (ja) 2010-05-12 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ccr2受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011144501A1 (en) 2010-05-17 2011-11-24 Boehringer Ingelheim International Gmbh Ccr2 antagonists and uses thereof
CN102260277B (zh) 2010-05-24 2013-07-24 中国科学院上海药物研究所 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
WO2011147772A1 (en) 2010-05-25 2011-12-01 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists
US8962656B2 (en) 2010-06-01 2015-02-24 Boehringer Ingelheim International Gmbh CCR2 antagonists
PE20130774A1 (es) 2010-07-29 2013-06-26 Rigel Pharmaceuticals Inc Compuestos heterociclicos activadores de ampk y metodos para emplearlos
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
CN104114538B (zh) * 2012-01-16 2016-04-13 葛兰素史克知识产权发展有限公司 治疗用途
AU2013211417A1 (en) * 2012-01-16 2014-07-31 Glaxosmithkline Intellectual Property Development Limited Therapeutic uses
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
PT3317270T (pt) 2015-07-02 2020-08-24 Centrexion Therapeutics Corp (4-((3r,4r)-3-metoxitetrahidro-pirano-4-ilamino)piperidina-1-il)(5-metil-6-(((2r,6s)-6-(p-tolil)tetrahidro-2h-pirano-2-il)metilamino)pirimidina-4-il)citrato de metanona
WO2017095758A1 (en) * 2015-12-01 2017-06-08 Merck Sharp & Dohme Corp. Homobispiperidinyl derivatives as liver x receptor beta agonists, compositions, and their use
EP4506344A4 (en) * 2022-03-31 2026-04-22 Bebetter Med Inc HETEROCYCLIC AROMATIC COMPOUND OR WITH A SUBSTITUTED AROMATIC NUCLEUS 1,4-DIHETEROCYCLIC AND ITS USE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
AU2002253929A1 (en) * 2001-02-08 2002-09-24 Schering Corporation Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders
WO2003031432A1 (en) * 2001-10-12 2003-04-17 Novo Nordisk A/S Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
JPWO2003104230A1 (ja) * 2002-06-07 2005-10-06 協和醗酵工業株式会社 二環性ピリミジン誘導体

Similar Documents

Publication Publication Date Title
JP2006528147A5 (https=)
JP6978507B2 (ja) Cftr増強物質としてのピロロピリミジン
JP6704398B2 (ja) 4H−ピロロ[3,2−c]ピリジン−4−オン誘導体
CN104125957B (zh) 取代的苄基吡唑
JP6387360B2 (ja) 変異idhの阻害薬としての3−ピリミジン−4−イル−オキサゾリジン−2−オン
KR101985050B1 (ko) 피라진카르복사미드 화합물
WO2012000304A1 (zh) 杂环炔苯类化合物及其药用组合物和应用
JP2017525757A5 (https=)
JP2013539777A5 (https=)
JP2011515462A5 (https=)
UA111754C2 (uk) Заміщені бензиліндазоли для застосування як інгібіторів bub1-кінази для лікування гіперпроліферативних захворювань
JP2008513514A5 (https=)
WO2011093501A1 (ja) Gpr119作動薬
JP2007524696A5 (https=)
JP2006508935A5 (https=)
JP2006506380A5 (https=)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
WO2012117996A1 (ja) Gpr119作動薬
WO2015152367A1 (ja) オキソ複素環誘導体
JP2021523177A5 (https=)
JP2019511466A (ja) オレキシン受容体調節因子としてのハロ置換ピペリジン
US20090149469A1 (en) Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors
JP2009501745A5 (https=)
JP2022534434A5 (https=)
JP2009537606A5 (https=)